Serum potassium levels, cardiac arrhythmias, and mortality following non-ST-elevation myocardial infarction or unstable angina: insights from MERLIN-TIMI 36

European Heart Journal: Acute Cardiovascular Care

Volumn 6, Issue 1, 2017, Pages 18-25

  Patel, Ravi B ^a   Tannenbaum, Sara ^a   Viana Tejedor, Ana ^b   Guo, Jianping ^a   Im, KyungAh ^a   Morrow, David A ^a   Scirica, Benjamin M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

acute coronary syndrome; Arrhythmias; cardiovascular death; myocardial infarction; potassium levels; ventricular tachycardia

Indexed keywords

GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; POTASSIUM; RANOLAZINE; TROPONIN I; CARDIOVASCULAR AGENT;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BRADYCARDIA; CARDIOVASCULAR MORTALITY; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART BEAT; HEART DISEASE; HEART VENTRICLE TACHYCARDIA; HOMEOSTASIS; HUMAN; MALE; MIDDLE AGED; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS; VENTRICULAR PAUSE; AGED; ARRHYTHMIAS, CARDIAC; BLOOD; COMPLICATION; CONTROLLED STUDY; METABOLISM; MORTALITY; RANDOMIZED CONTROLLED TRIAL;

AGED; ANGINA, UNSTABLE; ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR AGENTS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NON-ST ELEVATED MYOCARDIAL INFARCTION; POTASSIUM; RANOLAZINE;

EID: 85061424756     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872615624241     Document Type: Article

References (26)

1. Grumbach L, Howard JW, Merrill VI. Factors related to the initiation of ventricular fibrillation in the isolated heart; effect of calcium and potassium. Circ Res 1954; 2: 452–459.
2. Brown MJ, Brown DC, Murphy MB. Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med 1983; 309: 1414–1419.
3. Hulting J. In-hospital ventricular fibrillation and its relation to serum potassium. Acta Med Scand Suppl 1981; 647: 109–116.
4. Kafka H, Langevin L, Armstrong PW. Serum magnesium and potassium in acute myocardial infarction. Influence on ventricular arrhythmias. Arch Intern Med 1987; 147: 465–469.
5. Solomon RJ, Cole AG. Importance of potassium in patients with acute myocardial infarction. Acta Med Scand Suppl 1981; 647: 87–93.
6. Madias JE, Shah B, Chintalapally G. Admission serum potassium in patients with acute myocardial infarction: its correlates and value as a determinant of in-hospital outcome. Chest 2000; 118: 904–913.
7. Nordrehaug JE, Johannessen KA, von der Lippe G. Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction. Circulation 1985; 71: 645–649.
8. Friedensohn A, Faibel HE, Bairey O. Malignant arrhythmias in relation to values of serum potassium in patients with acute myocardial infarction. Int J Cardiol 1991; 32: 331–338.
9. Siscovick DS, Raghunathan TE, Psaty BM. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994; 330: 1852–1857.
10. Antman EM, Anbe DT, Armstrong PW. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110: e82–292.
11. Cohn JN, Kowey PR, Whelton PK. New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice. Arch Intern Med 2000; 160: 2429–2436.
12. Macdonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol 2004; 43: 155–161.
13. Goyal A, Spertus JA, Gosch K. Serum potassium levels and mortality in acute myocardial infarction. JAMA 2012; 307: 157–164.
14. Choi JS, Kim YA, Kim HY. Relation of serum potassium level to long-term outcomes in patients with acute myocardial infarction. Am J Cardiol 2014; 113: 1285–1290.
15. Scirica BM, Morrow DA. Potassium concentration and repletion in patients with acute myocardial infarction. JAMA 2012; 307: 195–196.
16. Morrow DA, Scirica BM, Karwatowska-Prokopczuk E. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the Merlin-TIMI 36 randomized trial. JAMA 2007; 297: 1775–1783.
17. Morrow DA, Scirica BM, Karwatowska-Prokopczuk E. Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes (Merlin)-TIMI 36 trial. Am Heart J 2006; 151: 1186.e1181–1189.
18. Antman EM, Cohen M, Bernink PJ. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000; 284: 835–842.
19. Podrid PJ. Potassium and ventricular arrhythmias. Am J Cardiol 1990; 65: 33E–44E; discussion 52E.
20. Weir MR, Bakris GL, Bushinsky DA. Patiromer in patients with kidney disease and hyperkalemia receiving raas inhibitors. N Engl J Med 2015; 372: 211–221.
21. Packham DK, Rasmussen HS, Lavin PT. Sodium zirconium cyclosilicate in hyperkalemia. N Engl J Med 2015; 372: 222–231.
22. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982; 247: 1707–1714.
23. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981; 304: 801–807.
24. Huikuri HV, Tapanainen JM, Lindgren K. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2003; 42: 652–658.
25. Goldberg RJ, Yarzebski J, Spencer FA. Thirty-year trends (1975–2005) in the magnitude, patient characteristics, and hospital outcomes of patients with acute myocardial infarction complicated by ventricular fibrillation. Am J Cardiol 2008; 102: 1595–1601.
26. Avezum A, Piegas LS, Goldberg RJ. Magnitude and prognosis associated with ventricular arrhythmias in patients hospitalized with acute coronary syndromes (from the Grace Registry). Am J Cardiol 2008; 102: 1577–1582.